#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14896	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2037	725.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1384	1384	C	892	C	834	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27064	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3367	799.1	0	.	n	.	0	T695C	SNP	695	695	T	931	931	C	851	C,T	790,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27064	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3367	799.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1573	1573	A	925	A,G	861,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27064	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3367	799.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2207	2207	C	856	C,T	791,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27064	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3367	799.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2281	2281	A	857	A	807	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27064	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3367	799.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2833	2833	C	838	C	792	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1854	folP	855	855	100.0	folP.l15.c30.ctg.1	1549	119.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1009	1011	AGC	189;188;188	A;G;C	181;180;179	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3390	145.7	1	SNP	p	S91F	1	.	.	271	273	TTC	644	646	TTC	182;184;184	T;T;C	172;173;172	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3390	145.7	1	SNP	p	G95N	0	.	.	283	285	GGC	656	658	GGC	180;179;179	G;G,A;C	172;167,1;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3390	145.7	1	SNP	p	D95G	1	.	.	283	285	GGC	656	658	GGC	180;179;179	G;G,A;C	172;167,1;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1436	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1441	99.4	1	SNP	p	G45D	0	.	.	133	135	GGC	570	572	GGC	182;183;182	G;G;C	168;165;169	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	760	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1058	71.7	0	.	n	.	0	A197.	DEL	197	197	A	571	571	A	167	A	160	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4886	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2947	165.1	1	SNP	p	D86N	0	.	.	256	258	GAC	523	525	GAC	176;177;177	G;A;C	162;161;163	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4886	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2947	165.1	1	SNP	p	R87I	0	.	.	259	261	CGT	526	528	CGT	178;179;180	C;G;T	165;164;165	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4886	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2947	165.1	1	SNP	p	R87W	0	.	.	259	261	CGT	526	528	CGT	178;179;180	C;G;T	165;164;165	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4886	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2947	165.1	1	SNP	p	S87R	1	.	.	259	261	CGT	526	528	CGT	178;179;180	C;G;T	165;164;165	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4886	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2947	165.1	1	SNP	p	S88P	0	.	.	262	264	TCC	529	531	TCC	179;182;183	T;C;C	165;166;167	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3918	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2578	151.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1504	1506	GGC	200;197;195	G;G,A;C,G	184;178,1;175,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1335	1337	GCA	201;205;205	G;C;A	187;187;191	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1338	1340	ATC	205;207;209	A;T;C	192;193;192	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1350	1352	GTG	201;201;200	G;T;G	183;182;182	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1350	1352	GTG	201;201;200	G;T;G	183;182;182	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1854	1856	ACC	180;180;186	A;C;C,A	164;168;170,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1908	1910	GCG	183;184;185	G;C;G,T	166;149;152,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1908	1910	GCG	183;184;185	G;C;G,T	166;149;152,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2031	2033	GGC	153;151;152	G;G;C	137;137;134	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2040	2042	GGC	151;150;151	G;G;C	137;132;133	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3692	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2553	144.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2058	2060	CCG	134;134;125	C,G;C;G	108,1;108;98	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	283	5270	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3063	171.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1456	1458	GGC	167;168;167	G;G;C	153;156;154	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1968	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1672	116.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	445	445	C	143	C	133	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	A29V	NONSYN	85	87	GCC	384	386	GTC	224;223;224	G;T;C,T	206;200;205,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	Y39H	NONSYN	115	117	TAC	414	416	CAC	216;219;224	C;A;C,T	202;202;208,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	T50A	NONSYN	148	150	ACT	447	449	GCT	244;243;244	G;C;T	222;224;225	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	K88L	NONSYN	262	264	AAA	561	563	CTC	261;262;261	C;T;C	241;242;241	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	S93N	NONSYN	277	279	AGC	576	578	AAC	266;264;261	A;A;C	243;240;242	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	H111R	NONSYN	331	333	CAT	630	632	CGT	232;232;236	C;G;T	212;211;216	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	N114S	NONSYN	340	342	AAC	639	641	AGC	230;230;231	A;G;C	214;211;208	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	I115V	NONSYN	343	345	ATC	642	644	GTC	229;233;233	G;T;C	210;211;213	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	L132S	NONSYN	394	396	TTG	693	695	TCG	262;259;260	T;C;G	245;242;244	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	Y201F	NONSYN	601	603	TAC	900	902	TTC	252;251;248	T;T;C,A	235;234;235,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	S236R	NONSYN	706	708	AGC	1005	1007	CGC	219;216;215	C;G,T;C	206;204,1;203	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	A249T	NONSYN	745	747	GCT	1044	1046	ACT	199;203;205	A;C;T	185;191;191	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2834	porB1a	984	984	98.17	porB1a.l15.c30.ctg.1	1425	198.2	0	.	p	.	0	A251V	NONSYN	751	753	GCG	1050	1052	GTG	211;209;207	G;T;G	200;196;196	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11092	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4819	229.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1294	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	956	134.5	1	SNP	p	V57M	1	.	.	169	171	ATG	490	492	ATG	251;250;255	A;T;G	240;238;244	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
